Download PDFPDF

AB0446 Additive inhibition of interferons, b and t cell activation and tfh-related cytokine cxcl13 by leflunomide and hydroxychloroquine supports rationale for combination therapy in pss patients
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address